New evidence supports the use of continuous glucose monitoring as a means to help control glycated hemoglobin levels in people with type 1 diabetes (T1D). The study, which compared continuous ...

A NEW point-of-care fingerstick test detects hepatitis B virus (HBV) within one hour, a 2026 diagnostic study has found. The ...

A clinical trial led by Kirby Institute at UNSW Sydney has found that point-of-care testing for hepatitis B DNA is as ...

A world-first Australian trial shows a simple fingerstick test can accurately detect hepatitis B DNA within an hour ...

Please provide your email address to receive an email when new articles are posted on . Adults with type 1 diabetes using intermittently scanned CGM had a greater HbA1c reduction than those using ...

Credence Research Inc. has released a new study on the Blood Glucose Monitoring Devices Market. According the report the Blood Glucose Monitoring Devices Market is projected to grow from USD 16,202.5 ...

STOCKHOLM, Sweden — Whether continuous glucose monitoring (CGM) is for "all" — and if not, for whom — was the topic of a lively debate at the recent European Association for the Study of Diabetes ...

A clinical trial has found that point-of-care testing for hepatitis B DNA is as effective as traditional laboratory testing, ...

According to World Health Organization estimates, around 254 million people were living with chronic hepatitis B infection in 2022. Yet only 14 percent had been diagnosed, and just 8 percent were ...